pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·4h ago·1 min read
save

Strategic CDMO partnerships shift from transactional to collaborative, emphasizing risk sharing and regulatory expertise

Oct 12, 2026·read at BioSpace ↗Positive

CDMO-sponsor relationships are moving away from simple outsourcing toward deeper strategic collaboration. Companies now look for partners who share risk, understand regulatory requirements, and provide technical insight.

Increasing compliance demands and geopolitical volatility are reshaping manufacturing, prompting sponsors to seek CDMOs that can anticipate and mitigate potential hurdles before they arise.

Jeff Mocny, vice president for Scientific Leadership at Rose BioSolutions, said the firm aims to challenge customer assumptions and protect programs early, rather than merely executing tasks.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Successful CDMO partnerships hinge on honest—and sometimes critical—support”

read at BioSpace ↗
1,121 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING3CYCLEPATH
topics
CRO/CDMO21Gene Therapy (AAV)2Diagnostics Company

related stories

  • 2d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Oct 5Swiss CDMOs and CROs ride a new wave of growth amid surge in global demandBioSpace
  • 6d agoGE HealthCare to acquire Sofie Biosciences for $945MBioPharma Dive
  • Sep 15FDA launches pilot program to speed up early US drug researchBioPharma Dive
  • Aug 26Beyond the Bandwidth Ceiling: Redesigning Advanced Therapy Operating Models for the Digital Staff EraFierce Biotech